Form 8-K - Current report:
SEC Accession No. 0001140361-26-027216
Filing Date
2026-07-01
Accepted
2026-07-01 16:20:55
Documents
12
Period of Report
2026-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20077152_8k.htm   iXBRL 8-K 37272
2 EXHIBIT 10.1 ef20077152_ex10-1.htm EX-10.1 817482
  Complete submission text file 0001140361-26-027216.txt   1139273

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vtrs-20260701.xsd EX-101.SCH 3862
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtrs-20260701_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtrs-20260701_pre.xml EX-101.PRE 16042
15 EXTRACTED XBRL INSTANCE DOCUMENT ef20077152_8k_htm.xml XML 4055
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

EIN.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39695 | Film No.: 261145447
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)